Is it safe to take Ambien (zolpidem) with Flexeril (cyclobenzaprine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concurrent Use of Ambien (Zolpidem) and Flexeril (Cyclobenzaprine)

Taking Ambien (zolpidem) with Flexeril (cyclobenzaprine) is not recommended due to the risk of additive central nervous system depression that can lead to excessive sedation, respiratory depression, and impaired psychomotor function.

Mechanism of Interaction

The combination of these medications presents several concerns:

  • Both medications have CNS depressant effects through different mechanisms:

    • Zolpidem acts on GABA receptors as a benzodiazepine receptor agonist 1
    • Cyclobenzaprine has recently been shown to be a potent non-competitive antagonist of histamine H1 receptors, contributing to its sedative effects 2
  • The combination creates overlapping sedative effects that can be dangerous and unpredictable

Risks of Concurrent Use

  1. Enhanced Sedation

    • Both medications independently cause sedation
    • Combined use significantly increases risk of excessive sedation
    • Cyclobenzaprine's H1 receptor antagonism adds to zolpidem's sedative effects
  2. Impaired Psychomotor Function

    • Increased risk of falls and accidents
    • Impaired driving ability
    • Decreased cognitive performance
  3. Respiratory Depression

    • Potential for additive respiratory depressant effects
    • Particularly concerning in patients with underlying respiratory conditions

Evidence from Guidelines

The American Academy of Sleep Medicine guidelines specifically warn about additive effects on psychomotor performance with concomitant CNS depressants when using zolpidem 1. The guidelines state:

"Additive effect on psychomotor performance with concomitant CNS depressants and/or alcohol use."

Additionally, FDA warnings for zolpidem highlight concerns about:

  • Disruptive sleep-related behaviors
  • Driving impairment
  • Memory impairment
  • Psychiatric adverse events 1

Alternative Approaches

If you are experiencing both insomnia and muscle spasms, consider these safer alternatives:

  1. For Insomnia:

    • Non-pharmacological approaches first (sleep hygiene education, cognitive behavioral therapy) 1
    • If medication is needed, consider using zolpidem alone at the lowest effective dose
    • Other options include eszopiclone, temazepam, or doxepin 1
  2. For Muscle Spasms:

    • Non-pharmacological approaches (physical therapy, proper hydration)
    • Consider using cyclobenzaprine alone during daytime hours only
    • Alternative muscle relaxants with less sedation may be considered

Special Considerations

  • Timing: If both medications are absolutely necessary, separate administration times as much as possible
  • Dose Reduction: Lower doses of both medications should be considered if concurrent use cannot be avoided
  • Monitoring: Close monitoring for excessive sedation and respiratory depression is essential
  • Elderly Patients: Particularly vulnerable to adverse effects; avoid this combination in older adults 1

Conclusion

The concurrent use of Ambien and Flexeril creates unnecessary risks due to their additive CNS depressant effects. Whenever possible, alternative treatment approaches should be pursued that don't involve this potentially dangerous drug combination.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.